Thailand COVID-19 Cases February 19. Thailand Ministry of Health reports 18,885 new COVID-19 cases and an additional 29 deaths since yesterday. The ministry also announced an additional 12,511 recovered patients.
The Department of Disease Control assured that there were few cases of side effects among the administered doses. There were 120 million doses administered in the country. This comprises 26.4 million Sinovac, 46.8 million AstraZeneca, 14.7 million Sinopharm, 27.6 million Pfizer, and 4.3 million Moderna doses.
Director of the Emergency Health Hazard and Disease Control, Dr. Chawetsan Namwat confirmed the data. He said that 79 people developed allergies with their vaccines. 43 affected by Sinovac and 22 by AstraZeneca. 31 people suffered from pericarditis after receiving doses. 29 attributed to Pfizer and one to Astrazeneca and one to Sinopharm. Thrombosis with thrombocytopenia was found in six people. Five of them received AstraZeneca jabs while one with Pfizer.
There were 2.081 complaints regarding deaths associated with vaccination. Only four were confirmed. Two from thrombosis with thrombocytopenia, one due to severe shock and one associated with Stevens-Johnson syndrome.
The other 177 deaths were associated with heart disease, intracerebral hemorrhage, and thrombosis. The other 938 were due to infected nervous system, pneumonitis, and other factors. The cause of death for the other complaints was not confirmed.
The Tourism Industry proposed to remove the second RT-PCR test required by the Test and Go scheme. The proposal was submitted to the Center for COVID-19 Situation Administration. The Tourism and Sports Ministry will propose to replace the second PCR test with an antigen test. If approved, it will be applied by March 1.